Abstract
An aging-related reduction in the brain’s functional reserve may explain why delirium is more frequent in the elderly than in younger people insofar as the reserve becomes inadequate to cover the metabolic requirements that are critically increased by stressors. The aim of this paper is to review the normal aging-related changes that theoretically compromise complex mental activities, neuronal and synaptic densities, and the neurocomputational flexibility of the functional reserve. A pivotal factor is diminished connectivity, which is substantially due to the loss of synapses and should specifically affect association systems and cholinergic fibres in delirious patients. However, micro-angiopathy with impaired blood flow autoregulation, increased blood/brain barrier permeability, changes in cerebrospinal fluid dynamics, weakened mitochondrial performance, and a pro-inflammatory involution of the immune system may also jointly affect neurons and their synaptic assets, and even cause the progression of delirium to dementia regardless of the presence of co-existing plaques, tangles, or other pathological markers. On the other hand, the developmental growth in functional reserve during childhood and adolescence makes the brain increasingly resistant to delirium, and residual reserve can allow the elderly to recover. These data support the view that functional reserve is the variable that confronts stressors and governs the risk and intensity of and recovery from delirium. Although people of any age are at risk of delirium, the elderly are at greater risk because aging and age-dependent structural changes inevitably affect the brain’s functional reserve.
Keywords: Aging, Brain, Delirium, Functional reserve
Introduction
In 2006, Speciale et al. [1] raised the question as to whether delirium, an “enormously impactful syndrome” [2] and a subject of semantic and research confusion [3, 4] since it was first described more than two thousand years ago, is a marker of brain fragility due to aging. This question was partially answered by the European Delirium Association and American Delirium Society [5], which established that delirium “is unquestionably a marker of [brain] vulnerability”. However, the relationship between brain vulnerability and aging has not been addressed with as much resolution probably because it is considered obvious given the phenomenology of aging, and so how aging may make the brain more susceptible to delirium is still a matter of speculation.
The aim of this paper is to consider the changes that occur in the brain during normal aging. It is assumed that these changes reduce the brain’s functional reserve, thus causing the fragility that may evolve into delirium more frequently in the elderly than in the young. In hospitalised subjects, the risk of delirium may increase from 3% in the young to 14% and 36% in the elderly aged 64–74 years and over [6]: i.e. about 2% per year after the age of 65 years [7].
Functional reserve and delirium
According to most experts, delirium is a confusional syndrome (“an acute disorder of attention and cognition”) [8] that develops because of the action of various stressors on fragile brain structures and their connections. Stressors act on nerve and glial cell systems via metabolic mediators, such as low energy levels following hypoxia, hypoglycemia and respiratory chain impairments, endo- and exotoxins, antibodies and autoantibodies, unbalanced ions, pH and osmolarity, drugs, and undue quantities of substantial metabolites and hormones. It is probably the balance between stressor strength and brain resilience that governs the risk and intensity of and recovery from delirium. Intuitively, brain resilience depends on the brain’s functional reserve, which diminishes with aging: as summarised by Inouye et al. [9] “delirium may serve as a marker of the vulnerable brain with diminished reserve capacity”.
The brain’s functional reserve has been defined as “the remaining capacity [of the brain] to fulfil its physiological activity, [particularly] in the context of disease […] or impairment” [10] of the brain itself and any organ or body system influencing its metabolism. Functional reserve is due to the interaction of complex mental activities, neural and synaptic densities, and neurocomputational flexibility [11], and may depend on the balance between brain connectivity and adaptive plasticity [12, 13], and the brain structures and energy available at any given moment. This suggests that the increased vulnerability of the elderly to delirium is because they have less functional reserve than the young [14]. According to the homeostenosis theory of the aging-related decline in reserve [15], which “matches the observation that the typical organ does not lose visible function so much as it loses measurable reserve” [16], delirium emerges when the reserve can no longer compensate for the effect of stressors. This view fits the conclusions of a meta-analysis of functional magnetic resonance imaging (fMRI) studies that the risk of delirium is related to the reduced structural connectivity of fragile networks, whereas the onset and course of clinical signs follow incidental dysfunctions of residual networks [17–19]. The question raised by Speciale et al. [1] may therefore be fully answered by considering aging-related structural and functional changes in the brain. Intuitively, the most relevant of these are changes in neuritic wiring and connectivity, cerebral blood flow (CBF), the blood-brain barrier (BBB), the dynamics of cerebrospinal fluid (CSF), the respiratory chain, and native immunity, which may also represent the postulate for some of the hypotheses concerning the origin of delirium [4, 20, 21]. Moreover, as might be expected, the effect of aging on functional reserve may be potentiated by the severity of concomitant diseases, pre-existing cognitive impairment, and reduced vision and hearing [22].
Aging-related brain changes, functional reserve, and delirium (Tables 1 and 2)
Table 1.
Aging-related brain changes
A. Morpho-functional changes peculiar to aging | |
1. Reduced | |
a. Neural connectivity due to shortening dendritic branches, with the loss of dendritic spines and synapses, the contraction of axonal fields, and the loss of myelinated axons, all revealed by decreased neurotransmitter and neurohormone levels | |
b. Cerebral blood flow due to micro-vessel stiffening, reduced vessel density, and deficient autoregulation | |
c. Respiratory chain efficiency | |
2. Increased blood-brain barrier permeability following changes in neurovascular components | |
3. Remodelled | |
a. Cerebrospinal fluid dynamics, with an increased fluid-to-brain volume ratio | |
b. Immunosurveillance leading to the pro-inflammatory status of microglia and macrophages | |
B. Incidental structural lesions common to diseases | |
a. Protein overload in cells, the neuropil, and vessel walls, with neuritic dystrophy and degeneration | |
b. Micro-infarcts and micro-bleeds |
Table 2.
Principal targets of morpho-functional changes in aging brain and their delirium-related effects (→)
A. Nerve cell systems | |
Associative thalamo-cortical and fronto-thalamic fibres | |
Brainstem activation system | |
Resting- and task-positive networks | |
Hypothalamic-pituitary-adrenal axis | |
Cholinergic systems | |
Melatonin-related systems | |
→ Decreased connectivity | |
B. Parenchymal vessels | |
Wall structure and neurovascular units: endothelium, smooth muscle fibres, basement membrane, astrocytes, pericytes, microglia, and nerve cell terminals | |
→ Inadequate blood flow and increased blood-brain barrier permeability | |
C. Plexus and ventricles | |
Ependyma, plexus vessels, and water pumps | |
→ Changes in cerebrospinal fluid dynamics | |
D. Respiratory chain | |
Mitochondria in nerve and glial cells, endothelia, and ependyma | |
→ Reduced efficiency | |
E. Immune system | |
Microglia and macrophages | |
→ Pro-inflammatory changes |
Connectivity
Brain shrinkage is a gross outcome of normal aging. The extent of the shrinkage was long debated until Fotenos et al. [23] used magnetic resonance imaging (MRI) to measure brain volume in 362 non-demented subjects aged 18–93 years and found that, after adjusting for head size, it was inversely related to age and was 0.22% per year (0.40% in the elderly). This study confirmed the findings of a previous study of 465 healthy subjects aged 18–79 years that revealed grey matter attenuation, particularly in the anterior cingulate, central, and angular gyri [24]. Shrinkage is due to cellular and sub-cellular changes, such as shortening dendritic branches [25], the loss of dendritic spines [26] and synapses [27], the shrinkage of large pyramidal neurons [28], the contraction of axonal fields [29], and centrum ovale re-modelling leading to a 45% loss of myelinated axons by the age of 80 years [30]. Although less dramatic than once believed [31, 32] and variably distributed [33, 34], these changes concur with lesions conventionally attributed to pathology (β-protein deposits in neuropil and vessel walls, neuronal and glial phospho-tau tangles, α-synuclein and TDP43 protein immunoreactive neurons, senile plaques [35], hippocampal sclerosis, micro-infarcts, and microbleeds) to reduce neuronal connectivity [36], energy metabolism [37], and neurotransmitter levels [4, 20]. Salthouse [38] looked for a relationship between cognitive decline and age-dependent changes, particularly MRI hyperintensities, and found that at most it was only weak. However, although this conclusion is in line with the concept of an asymptomatic burden of structural changes in brains that have aged cognitively well, as suggested by observations in the oldest old [39], it does not argue against the possibility that the changes may become symptomatic because of the action of stressors that absorb the functional reserve. In this regard, the interactions between changes and stressors may be expressed by the stressor-to-synapse ratio, which is expected to increase with aging.
There has been a long debate about which brain structures are the most vulnerable. Meynert [40] and Bonhoeffer [41] attributed delirium to the fragility of the thalamic and association systems supporting sensory perceptions, whereas Lipowski [42] and Plum and Posner [43] regarded delirium as a state of altered consciousness, thus implying that the main target was the brainstem activating system. Later, based on a longitudinal study of 100 delirious subjects (27 of whom were demented), Leonard et al. [44] maintained that delirium was the consequence of a thalamus-mediated cortical impairment, consistent with the slowing of electroencephalographic tracings [45, 46] and a global reduction in CBF [47, 48], whereas McLott et al. [49] speculated that post-operative delirium was related to abnormalities in thalamic inputs to the amygdala, hypothalamus, and periaqueductal grey matter. However, diffusion tensor imaging MRI (DTIMRI) allowed Cavallari et al. [50] to show that inter-hemispheric and fronto-thalamo-cerebellar networks were the most involved in patients with post-operative delirium. Trzepacz [51], who analysed functional and imaging studies of psychiatric patients and delirious patients sharing the same symptoms, reached more varied conclusions and suggested that the right or left prefrontal cortex, the anterior and right thalamus, or the right basilar mesial temporoparietal cortex may cause the core symptoms of delirium (e.g. disorientation, cognitive and language defects, a disordered sleep-wake cycle, disorganised thinking), whereas the ancillary symptoms (delusions, hallucinations, illusions, affective lability) depend on the causative disease. On the other hand, theories about the brain being organised into opposing resting- and task-positive networks [52] gave Sanders [53] the idea that delirium is due to abnormalities in their functional relationships. The structures active at rest include the postero-medial cortex, the medial pre-frontal cortex, and temporo-parietal junctions, whereas those activated by tasks include the posterior cingulate gyrus and the precuneus, dorso-, and ventrolateral pre-frontal cortex; the insula; and supplementary motor areas. Using fMRI, Choi et al. [54] found that rest- and task-activated structures were not functionally opposed in delirious subjects as they were in normal subjects and patients after recovery. Furthermore, some sub-cortical structures (the intralaminar thalamus, the striatum, the tegmentum, and the basal nucleus) were variably involved.
Changes in neurotransmitter balance, the sleep-wake cycle, and stress response dynamics have also been considered in the search for the more fragile structures. Reactions to stress start from the hippocampus and hypothalamus and, via the autonomic nervous system and pituitary gland, force the adrenal glands to increase noradrenaline and cortisol secretion (hence the definition of the hypothalamic-pituitary-adrenal [HPA] axis) to provide the body and mind with anti-stress support [55, 56]. In the limbic system (CA1 and CA3 hippocampus, dentate gyrus, basolateral amygdala) and medial pre-frontal and orbital frontal cortex (the most widely studied in laboratory animals for the presence of specific receptors), glucocorticoids may foster dendritic circuitry and modulate neurogenesis, but become neurotoxic over time. The shrinkage of the hippocampus, amygdala, and frontal cortex in the normal elderly and demented patients has been attributed to chronic stress and cortisol neurotoxic activity, but neurodegeneration could modify the cortisol set-up [57], increase diurnal cortisol secretion [58], and cause abnormal stress responses. On these grounds, MacLullich et al. [59] speculated that delirium may be due to stress responses that become harmful after HPA axis dysregulation possibly caused by inflammatory mediators.
Acetylcholine, dopamine, glutamine, GABA, serotonin, noradrenaline, tryptophan, phenylalanine, and histamine levels are decreased in the normal elderly [4, 20], and unbalanced in delirious patients [60]. Delirium is most frequently associated with reduced acetylcholine levels, excess dopamine, noradrenaline, and/or glutamate release, or uneven amounts in serotonin, histamine, and γ-aminobutyric acid [19]. However, cholinergic deficiency [61] has so far been the most widely accepted because of the confusional state caused by anti-cholinergic drugs and the possibility of recovery by means of cholinergic agents. A variant hypothesis based on an imbalance between cholinergic and adrenergic neurotransmitters has been suggested by Itil and Fink [62], who maintained that hyperactive forms are due to a prevalence of noradrenergic systems. A dopamine to acetylcholine imbalance might also be involved [51], as suggested by the existence of delirium due to opioids and drugs that promote dopamine release, and the anti-delirium efficacy of neuroleptic drugs that compete with dopamine. Guo et al. [63] have even suggested that glutamate-glutamine cycle dysfunction may explain post-surgical delirium. Multiple defects may lead to contrasting effects [64] as in the case of the susceptibility to delirium of Parkinsonian patients who have a prevalence of cholinergic over dopaminergic and monoaminergic neurons. In comparison, the normal elderly can rely on fewer striatal dopamine receptors balancing residual nigral neurons [65–67]: this lasting balance can appropriately support extrapyramidal functions under basal conditions, but it cannot easily combat stressors such as fever, infections, and neuroleptics.
The reduced duration, continuity, and quality of sleep in the old age [68, 69] all increase the risk of delirium. They are associated with lower levels of melatonin and structural changes in the networks supporting the sleep-wake cycle by means of circadian melatonin release [70], although this might be increased in hypoactive delirious patients [71]. Among the involved structures, Zhong et al. [72] listed the retinal-hypothalamic tract, the suprachiasmatic and galaninergic ventrolateral preoptic nuclei regulating the melatonin clock, orexinergic neurons in the hypothalamus, brainstem monoaminergic nuclei, hemispheric white matter, and the prefrontal cortex. However, sleep deprivation is supposedly responsible for so many dysfunctions [73, 74] that it may contribute to causing delirium [75] before becoming one of its leading symptoms.
Blood flow
CBF decreases with age [76] and, according to Amin-Hanjani et al. [77], who analysed MRI angiograms of 325 healthy subjects aged 18–84 years, and Zhang et al. [78], who used arterial spin labelling MRI (ASL-MRI), the reduction amounts to 2.6 mL/min and 0.38–0.45% every year. Aging also affects CBF autoregulation: i.e. the ability to compensate for blood pressure fluctuations and provide the brain with constant rates of oxygen and glucose by means of arterioles that shrink and expand in response to nervous and chemical inputs [79]. Aging could affect the neurons that regulate vascular tone (bipolar nerve cells in sub-cortical white matter and projections from the locus coeruleus, raphe, tegmentum, and nucleus basalis) [80, 81], and also affect autoregulation as a result of structural alterations in arterioles and capillaries, such as the attenuation of the endothelium with loss of mitochondria, changes in connective tissue and smooth muscle fibres, the thickening of basement membranes, microglia and pericyte proliferation, the decreased expression of water channels in astrocytic feet [82, 83], and β-protein overload. Additional modifications such as vessel tortuosity and collagenosis, string segments in the white matter [84], hyalinisation of vessel walls due to arteriolosclerosis and lipo-hyalinosis [85, 86], and the enlargement of perivascular spaces following an increased pulse rate indicate wall stiffening [87], which impairs the elastic reservoirs of pulse energy [88] and contributes to slowing CBF [79, 89]. These changes may be relevant to brain reserve insofar as they increase the risk of tissue hypoxia, metabolic stress, and nerve cell death [90] when blood pressure drops critically and, in the absence of autoregulation, prevents CBF from fulfilling tissue metabolic requirements. An additional risk may come from vessel density, which decreases with aging [91] despite attempts of capillary regrowth and repair [82], and the characteristics of some intra-parenchymal vessels: for example, a narrowing lumen of long penetrating arteries might predispose to chronic periventricular hypoxia, which can be revealed by MRI as leukoaraiosis. Nevertheless, the weight of MRI hyperintensities as a risk marker of delirium in selected surgical patients [92–94] has been questioned [95]. Likewise, an association between delirium and global or regional CBF abnormalities revealed by ASL-MRI before surgery proved to be doubtful [96], although low levels of cerebral oxygen saturation have been found to predict delirium after cardiac surgery in aged, neurologically impaired, or chronically hypoxic subjects [97].
Blood-brain barrier
Aging-related capillary changes affect the efficacy of the BBB, a neurovascular unit consisting of endothelial cells lying on a membrane surrounded by astrocytic feet, pericytes, nerve cell terminals, and microglia [98]. The tight junctions between endothelial cells, and cell-specific functions allow the BBB to act as an intercellular gate for water-soluble molecules and trans-cellular transfer machine for lipophilic agents, molecules carried by proteins, and substances that cross cells via receptors and vesicles [99–101]. In addition, astrocytes mediate metabolic traffic between blood and neurons [102], whereas pericytes control capillary flow [103]. Any changes in the neurovascular unit affect its functional coupling and lead to inaccurate permeabilities that challenge brain tissue and interstitial fluids with abnormal concentrations of ions, metabolites, and substances that otherwise remain or are transferred outside the brain. Erickson and Banks [104] have drawn attention to the reduced expression of proteins carrying glucose and insulin into the brain and β-protein outwards, and the increased intracerebral diffusion of plasma proteins through inter-cellular clefts. β-protein overload may also contribute to BBB breakdown [105].
The CSF-to-plasma albumin ratio has usually been used to follow the increase in BBB permeability during aging [106]. A dynamic contrast-enhanced MRI study of 113 cognitively normal subjects aged 21–83 years by Senatorov et al. [107] found that the increase begins in mid-life, and Chen et al. [108] have calculated that, in comparison with young barriers that can stop proteins with a molecular weight of >91.9 kDa, elderly barriers can be crossed by heavier molecules of up to 120 kDa. Some capillaries are more vulnerable to permeability failure than others, thus suggesting where BBB dysfunction may start. Montagne et al. [109] measured the MRI gadolinium blood-to-brain transfer constant in 24 non-demented subjects aged 23–91 years and found that BBB permeability increases with age in the capillaries of CA1 and the dentate gyrus of the hippocampus, but not in the capillaries of CA3 or other regions. According to Nation et al. [110], hippocampal BBB permeability is even more compromised in subjects with mild cognitive impairment and a CSF load of sPDGFRβ, a growth factor involved in angiogenesis but also a marker of pericyte damage. This suggests that pericytes might be the first victims of BBB breakdown, although it is the whole unit that suffers structural modifications during aging. Erdö et al. [111] have reviewed the literature on this point and listed a loss of endothelial cells, a reduction in the number of endothelial mitochondria and the expression of tight junction proteins (occludin, claudin, immunoglobulin), a thickening of the basement membrane coupled with decreased laminin content and increased collagen IV and agrin, abnormal bodies and larger mitochondria in the cytoplasm of pericytes, astrocytosis with glial fibrillary acidic protein overexpressed in astrocytic feet, and amoeboid microglia expressing pro-inflammatory mediators. Similar changes have been reproduced in models of BBB breakdown. Varatharaj and Galea [112] have reviewed studies of the pro-inflammatory effects of lipopolysaccharides on cell cultures and laboratory animals, and indicated abnormalities in transporters, prostaglandins, cytokines, tight junctions, astrocytes, and endothelial surfaces. Acharya et al. [113] reported that flurane anaesthetics can damage the proteoglycans and sialoproteins contained on the endothelial surfaces of laboratory animals and increase BBB permeability to plasma proteins. These changes were much more severe and lasted longer in older animals, which suggests that fluranes may be involved in post-surgical delirium in the elderly.
Cerebrospinal fluid
Aging-related changes in CSF have been attributed to oxidative damage and atrophy of the ependymal cells covering plexus and ventricles, and degeneration of the plexus vascular stems [114]. Each of the various components of CSF dynamics [115] is susceptible to senescence: its formation rate (500–600 mL/day is filtrated and secreted via the choroid plexus, ependyma, BBB, arachnoid surface, and modulated by endocrine mechanisms), pressure (100 cm H2O), flow (pulsatile from the plexus to subarachnoid spaces), turnover rate (up to 4-fold daily), volume (160 mL inversely related to turnover and intra-cranial blood volume), composition (99% water, with a very low protein content), sleep-related recycling via perivascular spaces and interstitial glymphatic networks, and reabsorption by lymphatic and venous streams. Combined with brain shrinkage, the overall effect of senescence on these parameters is an increase in the CSF-to-brain volume ratio [116, 117], which reflects reduced CSF formation (−50%), turnover, recycling, and reabsorption, and increased protein and glucose content with higher osmolarity [118]. Ventricular enlargement can also be magnified by hypoxia because of the over-expression of aquaporin 4, a water channel of pericapillary astrocytes that pumps water from the blood into interstitial spaces and may increase CSF water content [119, 120].
The findings of experimental studies [121, 122] indicate that aged CSF and changes in the BBB obstruct the adequate delivery of nutrients (glucose, vitamins, peptides, nucleosides, growth factors, etc.) to tissues via interstitial fluids and the total removal of harmful metabolites [123]. Particular attention has been paid to β-protein, which accumulates in grey matter during aging, particularly in subjects with Alzheimer’s disease. This apparently neurotoxic accumulation is probably due to an imbalance in the activity of RAGE (a receptor for advanced glycation end products) and LRP-1 (low-density lipophilic receptor-associated protein 1), which reside in plexus epithelia and capillary endothelia [124]. The former moves β-protein from the blood into interstitial fluids and CSF, and the latter does the opposite [125, 126]. Aging increases the expression of RAGE and decreases that of LRP-1 [127], and thus drives β-protein turnover towards accumulation. The generation of β-protein is stimulated by aging-related chronic hypoxia, glucose deprivation [128–130], and sleep dysfunctions [131, 132], and its neurotoxicity may be strengthened by the aging-related decreased expression of transthyretin, a protein that is secreted by plexus and binds and blocks β-protein [114, 133].
Respiratory chain
Aging impairs cellular respiration because of a mitochondrial dysfunction that lessens ATP production by 8% every ten years, and even more in sedentary, overweight subjects [134]. Furthermore, mitochondria cross reduced antioxidant defences and accumulate reactive oxygen species, thus leading to oxidative stress and the generation of mitochondrial DNA mutations, a loss of efficient energy metabolism, and metabolic changes that progress to cell degeneration and apoptosis. Harman [135] suggested that this process, which induces muscle volume to shrink from mid-life onwards, was the basic mechanism of aging but it is now regarded as just part of the involution of various interactive cell pathways [136]. However, it has been suggested that delirium is related to oxidative neuronal stress because oxygen saturation and catalase levels are consistently lowered in delirious post-operative patients [137, 138]. Neurons are particularly vulnerable to mitochondrial impairment and anaerobic metabolism, and the consistently increased lactate levels in elderly brains due to mitochondrial involvement may be a marker of aging in general [139]. The hypoxic vulnerability of neurons is related to the fact that they depend on oxidative phosphorylation to satisfy their energy needs. A review by Grimm and Eckert [140] describes neurons as life-long cells that cannot retain the mitochondrial assets received at birth because of the failure of mitochondrial functions of paramount importance, such as fusion and fission dynamics, debris autophagy, and the ability to increase energy production when required. It is possible that mitochondrial vulnerability to aging is greater in the neuronal compartments that require more energy, particularly the synaptic terminals and axons at the level of the nodes of Ranvier, which suggests that mitochondrial aging is a critical event that consistently affects neuronal connectivity.
Little is known about the mitochondrial aging of glial cells or its neuronal effects, but Jiang and Cadenas [141] have reported increased energy production by astrocytes at the expense of neurons, which suggests that aging is associated with a detrimental change in the previously protective neuro-centred functions of astrocytes.
Microglia and macrophages
The word “inflammaging” was coined by Franceschi et al. [142] to define the pro-inflammatory state of the immune system induced by life-long antigen pressure and stress [143], which can generate an immuno-senescence that favours the onset of aging-related diseases. This generalised involution also affects microglia (the resident immune cells that protect the brain against organic intruders) by eventually allowing them to develop a neurotoxic pro-inflammatory phenotype. According to Cornejo and von Bernhardi [144] and many others who have studied the subject [145–147], aging microglia are characterised by molecular changes (an increased expression of pro-inflammatory cytokines, inflammatory and toll-like receptors and signalling, a decreased expression of anti-inflammatory cytokines and the activation of inhibitory factors, and the overproduction of reactive oxygen species) that make them abnormally primed and unfit to do their work. The morphology and dynamics of senescent microglia are in line with changes in their younger functions [148, 149] as they show an increased propensity for proliferation and enlargement. Their cytoplasm is fragmented, and the residual processes are thicker, less ramified, and poorly reactive to extra-cellular signals of injury. These changes lead to exaggerated inflammatory responses and simultaneously impaired ability to catch and phagocyte intruders [150]. Two additional phenotypes (rod-shaped and dark microglia) have been described in elderly humans [151] and mice [152], but it is doubtful that they are pertinent to normal aging. Unlike microglia, brain macrophages derived from circulating monocytes become more anti-inflammatory and less prone to proliferation; however, they are functionally like aging microglia as they do not activate phagocytosis as effectively as when they were young [153]. In addition, a senescent BBB may interfere with their ability to cross vessel walls, which normally occurs at venule level. Conversely, increased BBB permeability allows plasma albumin to enter astrocytes and over-activate neurotoxic cytokines [107], particularly in patients whose peripheral inflammation is responsible for further endothelial and perivascular cell involvement [154]. Perry and Holmes [155] have underlined the role of β-protein and misfolded proteins in microglial priming, whereas Safaiyan et al. [156] have observed microglia that become senescent after accumulating membrane debris from myelin turnover.
“Inflammaging” implies that aging-related inflammation can promote delirium, and so cytokines capable of mediating the detrimental effect of stressors on the brain (and possibly modifying the release of neurotransmitters [157] and activating the HPA axis) [55, 158, 159] may be markers of delirium. Peripheral inflammation and infections are powerful humoral and cell-mediated stressors that reach the brain via the blood and the vagus nerve and stimulate innate immune cells to produce pro-inflammatory cytokines [160, 161]. Interleukin-6 (IL-6) may be the best peripheral marker of delirium as it is not only detectable in plasma and CSF samples from delirious post-surgical and post-stroke patients [158, 162–167], but also in brain tissue together with markers of astroglial and microglial activation [168]; however, plasma and CSF C-reactive protein, tumour necrosis factor α, IL-1α and 1ß, IL-8, IL-10, and soluble IL-1 and IL-6 receptor antagonist levels may be equally important [169–174]. On the other hand, these diagnostic markers have no predictive value as they are undetectable before the onset of delirium [175].
Comments
This overview argues that senescence involves many entwined changes that deplete the structural and metabolic resources supporting cerebral functions and reserves, thus making the brain increasingly vulnerable to the progression of stress to a state of delirium without precluding recovery. The relationships between these magnitudes can be transformed into the proportion delirium : recovery = stressor : reserve, which indicates that functional reserve and stressor strength are factors that act in opposition to each other to govern not only the individual risk and severity of delirium, but also the prospect of recovery, thus explaining why the aim of treating delirium is to weaken stressors and strengthen reserve.
If a decreasing reserve predisposes to delirium, residual reserve and the capacity to resist stressors may not only partially explain differences in individual resilience, but also allow the brain to recover. This was first pointed out by Meynert [40], who coined the word “amentia” to connote confusion as the clinical hallmark of delirium and underline the fact that, unlike dementia, delirium is not necessarily irreversible. Nevertheless, despite residual reserve, delirium can increase the risk of incident dementia [176, 177], accompany long-term cognitive decline [178], and worsen the severity of pre-existing dementia [179, 180]. Davis et al. [181, 182] have investigated whether the acceleration of cognitive decline in later life induced by delirium is influenced by the tangles, plaques, Lewy bodies, micro-infarcts, and micro-bleeds associated with aging that may cause late-onset dementia. Their study of 987 brain donors (mean age at death 90 years, median follow-up 5.2 years, 279 with delirium) showed that the conversion of delirium to dementia is not influenced by the burden of the lesions conventionally associated with dementia; they concluded that “additional […] pathologic processes [should] specifically relate to delirium”, and suggested inflammation as one of these. A complementary study by Erten-Lyons et al. [183] investigated the progression of brain disease and atrophy in 71 elderly subjects and the authors concluded that the burden of Alzheimer-type and vascular lesions does not justify the amount of brain atrophy in patients with mild cognitive impairment and dementia, thus suggesting the involvement of other factors. These findings may argue against the conventional view that there is a continuum between normal aging and late-onset Alzheimer’s disease based on the progression and increasing burden of plaques and tangles in both conditions [184] and support the pathogenic role of aging-related and stressor-mediated structural changes that are accelerated and increased by particularly severe, recurrent, and long-standing delirium. In other words, stressors may not only drain functional reserve and lead to the onset of delirium but, depending on their severity and the duration of delirium, simultaneously increase the burden of common aging-related changes in CBF, BBB, CSF dynamics, the respiratory chain, immunosurveillance, and, finally, connectivity. One example of the multiple consequences of even a single stressor on the aging brain is COVID-19 encephalopathy [185, 186].
The difficulty of assigning these changes a recognisable dimension is due to the difficulty of assessing and following them during life to identify traits that are comparable with those of dementia. However, some instrumental data have been obtained from delirious patients that are consistent with recovery or ongoing neurodegeneration. Yokota et al. [47] used xenon-enhanced computed tomography to measure CBF in delirious patients, and found that it was significantly reduced at the level of the frontal, temporal, and occipital cortex; the thalamus; and basal ganglia, but normalised after delirium regression, and Choi et al. [54] found that fMRI abnormalities involving the connections between the dorsolateral, prefrontal, and posterior cingulate cortex can disappear after recovery, although van Montfort et al. [16] used the same experimental design and found that functional abnormalities persisted. Sharshar et al. [187] have reported that MRI perivascular hyperintensities in the white matter of patients with septic shock had a poor outcome that was attributed to abnormally increased BBB permeability. Morandi et al. [188] studied the structure of corpus callosum and internal capsule white matter in 47 delirious patients by means of DTI-MRI and found that reduced fractional anisotropy values indicating white matter disruption persisted for a long time in association with worse cognitive scores. Similar changes were found by Cavallari et al. [189] in the periventricular, frontal, and temporal white matter of 25 subjects presenting cognitive decline one year after post-operative delirium. Prolonged delirium may be responsible for reduced frontal lobe and hippocampal volume [190], and worse global cognition and executive function scores after three and 12 months [5]. According to van Munster et al. [191], increased plasma levels of astrocytic protein S100 may be a marker of brain tissue damage in delirious patients.
Concluding remarks
Although elderly subjects are at much higher risk of delirium than the young, children and adolescents are also at high risk. A review by Hatherill and Flisher [192] has described prevalence rates of 17–66% among referrals from paediatric intensive care units, and others have reported rates of 4–29% and 13–44% [193, 194]. The size of the intervals has been attributed to methodological differences in diagnostic procedures [194, 195], but a complementary explanation might be age, given that delirium occurs more frequently in children aged <5 years and its prevalence peaks at 56% [196] before the age of two years [194, 196]. The reduction in the prevalence of delirium as children and adolescents become older indicates that the ongoing organisation of neuronal hierarchies in myelinogenetic cycles, and the maturation of barrier and ependyma, blood flow autoregulation, native immunity etc., allows functional reserve to increase during brain development as much as it decreases during aging following the onset and progression of structural and functional changes. Taken together, these data show a U-shaped distribution of brain vulnerability to delirium in relation to age, which reflects the availability of functional reserve and supports the relevance of its pathogenic role in lifetime delirium.
Acknowledgements
Dr. Kevin R. Smart is kindly acknowledged for reviewing the manuscript.
Declarations
Conflict of interest
None
Ethical approval
None
Informed consent
None
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Speciale S, Bellelli G, Turco R, Trabucchi M. Il delirium: marker dell’evoluzione clinica di un anziano fragile affetto da patologia acuta? G Gerontol. 2006;54:28–40. [Google Scholar]
- 2.MacLullich AM, Hall RJ. Who understands delirium? Age Ageing. 2011;40:412–414. doi: 10.1093/ageing/afr062. [DOI] [PubMed] [Google Scholar]
- 3.Bugiani O. Deciphering delirium through semantics. A selective synopsis. Neurol Sci. 2020;42:2147–2151. doi: 10.1007/s10072-020-04438-x. [DOI] [PubMed] [Google Scholar]
- 4.Maldonado JR. Delirium pathophysiology: an updated hypothesis of the aetiology of acute brain failure. Int J Geriatr Psychiatry. 2018;33:1428–1457. doi: 10.1002/gps.4823. [DOI] [PubMed] [Google Scholar]
- 5.European Delirium Association; American Delirium Society The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Med. 2014;12:141. doi: 10.1186/s12916-014-0141-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW, BRAIN-ICU Study Investigators Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369:1306–1316. doi: 10.1056/NEJMoa1301372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pendlebury ST, Lovett NG, Smith SC, Dutta N, Bendon G, Lloyd-Lavery A, Mehta Z, Rothwell PM. Observational, longitudinal study of delirium in consecutive unselected acute medical admissions: age-specific rates and associated factors, mortality and re-admissions. BMJ Open. 2015;5:e007808. doi: 10.1136/bmjopen-2015-007808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Oh ES, Akeju O, Avidan MS, Cunningham C, Hayden KM, Jones RN, Khachaturian AS, Khan BA, Marcantonio ER, Needham DM, Neufeld KJ, Rose L, Spence J, Tieges Z, Vlisides P, Inouye SK, NIDUS Writing Group A roadmap to advance delirium research: recommendations from the NIDUS Scientific Think Tank. Alzheimers Dement. 2020;16:726–733. doi: 10.1002/alz.12076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383:911–922. doi: 10.1016/S0140-6736(13)60688-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.https://en.wiktionary.org/w/index.php?title:functionalreserve&oldid=41600298 (2016)
- 11.Valenzuela MJ. Brain reserve and the prevention of dementia. Curr Opin Psychiatry. 2008;21:296–302. doi: 10.1097/YCO.0b013e3282f97b1f. [DOI] [PubMed] [Google Scholar]
- 12.Gray DT, Barnes CA. Distinguishing adaptive plasticity from vulnerability in the aging hippocampus. Neuroscience. 2015;309:17–28. doi: 10.1016/j.neuroscience.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shafi MM, Santarnecchi E, Fong TG, Jones RN, Marcantonio ER, Pascual-Leone A, Inouye SK. Advancing the neurophysiological understanding of delirium. J Am Geriatr Soc. 2017;65:1114–1118. doi: 10.1111/jgs.14748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Taffett GE. Physiology of aging. In: Cassel CK, editor. Geriatric medicine: an evidence-based approach. 4. New York: Springer; 2006. pp. 27–35. [Google Scholar]
- 15.Resnick NM. Geriatric medicine. In: Isselbacher KJ, Braunwald E, editors. Harrison’s principles of internal medicine. 13. New York: McGraw-Hill; 1994. pp. 30–36. [Google Scholar]
- 16.Troncale JA. The aging process. Physiologic changes and pharmacologic implications. Postgrad Med. 1996;99(111-114):120–122. [PubMed] [Google Scholar]
- 17.van Montfort SJ, van Dellen E, van den Bosch AM, Otte WM, Schutte MJ, Choi SH, Chung TS, Kyeong S, Slooter AJ, Kim JJ. Resting-state fMRI reveals network disintegration during delirium. Neuroimage Clin. 2018;20:35–41. doi: 10.1016/j.nicl.2018.06.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.van Montfort SJ, van Dellen E, Stam CJ, Ahmad AH, Mentink LJ, Kraan CW, Zalesky A, Slooter AJ. Bain network disintegration as a final common pathway for delirium: a systematic review and qualitative meta-analysis. Neuroimage Clin. 2019;23:100809. doi: 10.1016/j.nicl.2019.101809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.van Montfort SJ, Slooter AJC, Kant IM, van der Leur RR, Spies C, de Bresser J, Witkamp TD, Hendrikse J, van Dellen E. fMRI network correlates of predisposing risk factors for delirium: a cross-sectional study. Neuroimage Clin. 2020;27:102347. doi: 10.1016/j.nicl.2020.102347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013;21:1190–1222. doi: 10.1016/j.jagp.2013.09.005. [DOI] [PubMed] [Google Scholar]
- 21.Wang Y, Shen X. Postoperative delirium in the elderly: the potential neuropathogenesis. Aging Clin Exp Res. 2018;30:1287–1295. doi: 10.1007/s40520-018-1008-8. [DOI] [PubMed] [Google Scholar]
- 22.Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability JAMA. 1996;275:852–857. [PubMed] [Google Scholar]
- 23.Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol. 2008;65:113–120. doi: 10.1001/archneurol.2007.27. [DOI] [PubMed] [Google Scholar]
- 24.Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackoviak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14:21–36. doi: 10.1006/nimg.2001.0786. [DOI] [PubMed] [Google Scholar]
- 25.Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease. Neurobiol Aging. 1987;8:521–545. doi: 10.1016/0197-4580(87)90127-8. [DOI] [PubMed] [Google Scholar]
- 26.Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci. 2004;27:607–612. doi: 10.1016/j.tins.2004.07.013. [DOI] [PubMed] [Google Scholar]
- 27.Peters A, Sethares C, Luebke JI. Synapses are lost during aging on the primate prefrontal cortex. Neuroscience. 2008;152:970–981. doi: 10.1016/j.neuroscience.2007.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Terry DR, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21:530–539. doi: 10.1002/ana.410210603. [DOI] [PubMed] [Google Scholar]
- 29.Adalbert R, Coleman MP. Axon pathology in age-related neurodegenerative disorders. Neuropathol Appl Neurobiol. 2013;39:90–108. doi: 10.1111/j.1365-2990.2012.01308.x. [DOI] [PubMed] [Google Scholar]
- 30.Marner L, Nyengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 2003;462:144–152. doi: 10.1002/cne.10714. [DOI] [PubMed] [Google Scholar]
- 31.Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nat Rev Neurosci. 2006;7:30–40. doi: 10.1038/nrn1809. [DOI] [PubMed] [Google Scholar]
- 32.Pannese E. Morphological changes in nerve cells during normal aging. Brain Struct Funct. 2011;216:85–89. doi: 10.1007/s00429-011-0308-y. [DOI] [PubMed] [Google Scholar]
- 33.Juraska JM, Lowry NC. Neuroanatomical changes associated with cognitive aging. Curr Top Behav Neurosci. 2012;10:137–162. doi: 10.1007/7854_2011_137. [DOI] [PubMed] [Google Scholar]
- 34.Grillo FW. Long live the axon. Parallels between ageing and pathology from a presynaptic point of view. J Chem Neuroanat. 2016;76:28–34. doi: 10.1016/j.jchemneu.2015.12.005. [DOI] [PubMed] [Google Scholar]
- 35.Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabel S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol. 2013;126:365–384. doi: 10.1007/s00401-013-1157-y. [DOI] [PubMed] [Google Scholar]
- 36.Salat DH. The declining infrastructure of the aging brain. Brain Connect. 2011;1:279–293. doi: 10.1089/brain.2011.0056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kochunov P, Ramage AE, Lancaster JL, Robin DA, Narayama S, Coyle T, Royall DR, Fox P. Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage. 2009;45:17–28. doi: 10.1016/j.neuroimage.2008.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Salthouse TA. Neuroanatomical substrates of age-related cognitive decline. Psychol Bull. 2011;137:753–784. doi: 10.1037/a0023262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bugiani O. The puzzle of preserved cognition in the oldest old. Neurol Sci. 2020;41:441–447. doi: 10.1007/s10072-019-04111-y. [DOI] [PubMed] [Google Scholar]
- 40.Meynert T. Amentia, der Vervirrtheit. Jb Psychiat. 1890;9:1–112. [Google Scholar]
- 41.Bonhoeffer K. Zur Frage der Klassifikation der symptomatischen Psychosen. Berl Klin Wschr. 1908;45:2257–2260. [Google Scholar]
- 42.Lipowski ZJ. Delirum, clouding of consciousness and confusion. J Nerv Ment Dis. 1967;145:227–255. doi: 10.1097/00005053-196709000-00006. [DOI] [PubMed] [Google Scholar]
- 43.Plum F, Posner JB. The diagnosis of stupor and coma. 3. Philadelphia: Davis; 1980. [Google Scholar]
- 44.Leonard M, Adamis D, Saunders J, Trzepacz P, Meagher D. A longitudinal study of delirium phenomenology indicates widespread neural dysfunction. Palliat Support Care. 2015;13:187–196. doi: 10.1017/S147895151300093X. [DOI] [PubMed] [Google Scholar]
- 45.Jacobson S, Jerrier H. EEG in delirium. Semin Clin Neuropsychiatry. 2000;5:86–92. doi: 10.153/SCNP00500086. [DOI] [PubMed] [Google Scholar]
- 46.Kimchi EY, Neelagiri A, Whitt W, Sagi AR, Ryan SI, Gadbois G, Groothuysen D, Westover MB. Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes. Neurology. 2019;93:e1260–e1271. doi: 10.1212/WNL.0000000000008164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yokota H, Ogawa S, Kurokawa A, Yamamoto Y. Regional blood flow in delirium patients. Psychiatry Clin Neurosci. 2003;57:337–339. doi: 10.1046/j.1440-1819.2003.01126.x. [DOI] [PubMed] [Google Scholar]
- 48.Fong TG, Bogardus ST, Jr, Daftary A, Auerbach E, Blumenfeld H, Modur S, Leo-Summers L, Seibyl J, Inouye SK. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006;61:1294–1299. doi: 10.1093/gerona/61.12.1294. [DOI] [PubMed] [Google Scholar]
- 49.McLott J, Jurecic J, Hemphill L, Dunn KS. Development of an amygdalocentric neurocircuitry-reactive aggression theoretical model of emergence delirium in posttraumatic stress disorder: an integrative literature review. AANA J. 2013;81:379–384. [PubMed] [Google Scholar]
- 50.Cavallari M, Dai W, Guttmann CR, Meier DS, Ngo LH, Hshiech TT, Callahan AE, Fong TG, Schmitt E, Dickerson BC, Press DZ, Marcantonio ER, Jones RN, Inouye SK, Alsop DC, SAGES Study Group Neural substrates of vulnerability to postsurgical delirium as revealed by presurgical diffusion MRI. Brain. 2016;139:1282–1294. doi: 10.1093/brain/aww010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Trzepacz PT. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord. 1999;10:330–334. doi: 10.1159/000017164. [DOI] [PubMed] [Google Scholar]
- 52.Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA. 2005;102:9673–9678. doi: 10.1073/pnas.0504136102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sanders RD. Hypothesis for the pathophysiology of delirium: role of baseline brain network connectivity and changes in inhibitory tone. Med Hypotheses. 2011;77:140–143. doi: 10.1016/j.mehy.2011.03.048. [DOI] [PubMed] [Google Scholar]
- 54.Choi SH, Lee H, Chung TS, Park KM, Jung YC, Kim SI, Kim JJ. Neural network functional connectivity during and after an episode of delirium. Am J Psychiatry. 2012;169:498–507. doi: 10.1176/appi.ajp.2012.11060976. [DOI] [PubMed] [Google Scholar]
- 55.Joëls M. Impact of glucocorticoids on brain functions: relevance for mood disorders. Psychoneuroendocrinology. 2011;36:406–414. doi: 10.1016/j.psyneuen.2010.03.004. [DOI] [PubMed] [Google Scholar]
- 56.Lupien SJ, Juster RP, Raymond C, Marin MF. The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity. Front Neuroendocrinol. 2018;49:91–10557. doi: 10.1016/j.yfrne.2018.02.001. [DOI] [PubMed] [Google Scholar]
- 57.Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464:529–535. doi: 10.1038/nature08983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Gaffey AE, Bergeman CS, Clark LA, Wirth MM. Aging and the HPA axis: stress and resilience in older adults. Neurosci Biobehav Rev. 2016;68:928–945. doi: 10.1016/j.neubiorev.2016.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.MacLullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res. 2008;65:229–238. doi: 10.1016/j.jpsychores.2008.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.White S. The neuropathogenesis of delirium. Rev Clin Gerontol. 2002;12:62–67. doi: 10.1017/S0959259802012182. [DOI] [Google Scholar]
- 61.Lipowski ZJ. Delirium: acute confusional states. Oxford: Oxford University Press; 1990. [Google Scholar]
- 62.Itil T, Fink M. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations. J Nerv Ment Dis. 1966;143:492–507. doi: 10.1097/00005053-196612000-00005. [DOI] [PubMed] [Google Scholar]
- 63.Guo Y, Zhang Y, Jia P, Wang W, Zhou Q, Sun L, Zhao A, Zhang X, Wang X, Li Y, Zhang J, Jiang W. Preoperative serum metabolites are associated with postoperative delirium in elderly hip-fracture patients. J Gerontol A Biol Sci Med Sci. 2017;72:1689–1696. doi: 10.1093/gerona/glx001. [DOI] [PubMed] [Google Scholar]
- 64.Maldonado JR. Delirium in the acute care setting: characteristics, diagnosis, and treatment. Crit Care Clin. 2008;24:657–722. doi: 10.1016/j.ccc.2008.05.008. [DOI] [PubMed] [Google Scholar]
- 65.McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol. 1977;34:33–35. doi: 10.1001/archneur.1977.00500130053010. [DOI] [PubMed] [Google Scholar]
- 66.Bugiani O, Salvarani S, Perdelli F, Mancardi GL, Leonardi A. Nerve cell loss with aging in the putamen. Eur Neurol. 1978;17:286–291. doi: 10.1159/000114960. [DOI] [PubMed] [Google Scholar]
- 67.Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, Logan J, Moberg PJ, Hitzemann R, Smith G, Pappas N. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging. Ann Neurol. 1998;44:143–147. doi: 10.1002/ana.410440125. [DOI] [PubMed] [Google Scholar]
- 68.Dijk DJ, Duffy JF, Riel E, Shanahan TL, Czeisler CA. Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin, and temperature rhythms. J Physiol. 1999;516:611–627. doi: 10.1111/j.1469-7793.1999.0611v.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Kim JH, Duffy JF. Circadian rhythm sleep-wake disorders in older adults. Sleep Med Clin. 2018;13:39–50. doi: 10.1016/j.jsmc.2017.09.004. [DOI] [PubMed] [Google Scholar]
- 70.Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DR. Melatonin and sleep in aging population. Exp Gerontol. 2005;40:911–925. doi: 10.1016/j.exger.2005.08.009. [DOI] [PubMed] [Google Scholar]
- 71.Balan S, Leibovitz A, Zila SO, Ruth M, Chana W, Yassica B, Rahel B, Richard G, Neumann E, Blagman B, Habot B. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatr Clin Neurosci. 2003;15:363–366. doi: 10.1176/jnp.15.3.363. [DOI] [PubMed] [Google Scholar]
- 72.Zhong HH, Yu B, Luo D, Yang LY, Zhang J, Jiang SS, Hu SJ, Luo YY, Yang MW, Hong FF, Yang SL. Roles of aging in sleep. Neurosci Biobehav Rev. 2019;98:177–184. doi: 10.1016/j.neubiorev.2019.01.013. [DOI] [PubMed] [Google Scholar]
- 73.Cardinali DP, Pévert P. Basic aspects of melatonin action. Sleep Med Rev. 1998;2:175–190. doi: 10.1016/S1087-0792(98)90020-X. [DOI] [PubMed] [Google Scholar]
- 74.McEwen BS, Karatsoreos IN. Sleep deprivation and circadian disruption. Stress, allostasis, and allostatic load. Sleep Med Clin. 2015;10:1–10. doi: 10.1016/j.jsmc.2014.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175:3190–3199. doi: 10.1111/bph.14116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Stoquart-ElSankari S, Balédent O, Gondry-Jouet C, Makki M, Godefroy O, Meyer ME. Aging effects on cerebral blood and cerebrospinal fluid flows. J Cereb Blood Flow Metab. 2007;27:1563–1572. doi: 10.1038/sj.jcbfm.9600462. [DOI] [PubMed] [Google Scholar]
- 77.Amin-Hanjani S, Du X, Pandey DK, Thulborn KR, Charbel FT. Effect of age and vascular anatomy on blood flow in major cerebral vessels. J Cereb Blood Flow Metab. 2015;35:312–318. doi: 10.1038/jcbfm.2014.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Zhang N, Gordon ML, Goldberg TE. Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer’s disease. Neurosci Biobehav Rev. 2017;72:168–175. doi: 10.1016/j.neubiorev.2016.11.023. [DOI] [PubMed] [Google Scholar]
- 79.Peterson EC, Wang Z, Britz G. Regulation of cerebral blood flow. Int J Vasc Med doi. 2011;2011:1–8. doi: 10.1155/2011/823525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Okhotin VE, Kalinichenko SG. Subcortical white matter interstitial cells: their connections, neurochemical specialization, and role in the histogenesis of the cortex. Neurosci Behav Physiol. 2003;33:177–194. doi: 10.1023/A:1021778015886. [DOI] [PubMed] [Google Scholar]
- 81.Drake CT, Iadecola C. The role of neuronal signaling in controlling cerebral blood flow. Brain Lang. 2006;102:141–152. doi: 10.1016/j.bandl.2006.08.002. [DOI] [PubMed] [Google Scholar]
- 82.Kalaria RN. Cerebral vessels in ageing and Alzheimer’s disease. Pharmacol Ther. 1996;72:193–214. doi: 10.1016/S0163-7258(96)00116-7. [DOI] [PubMed] [Google Scholar]
- 83.Duncombe J, Lennent RJ, Jansen MA, Marshall I, Wardlaw JM, Horsburgh K. Ageing causes prominent neurovascular dysfunction with loss of astrocytic contacts and gliosis. Neuropathol Appl Neurobiol. 2017;43:477–491. doi: 10.1111/nan.12375. [DOI] [PubMed] [Google Scholar]
- 84.Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37:56–74. doi: 10.1111/j.1365-2990.2010.01139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Craggs LJ, Yamamoto Y, Deramecourt V, Kalaria RN. Microvascular pathology and morphometrics in sporadic and hereditary small vessel diseases of the brain. Brain Pathol. 2014;24:495–509. doi: 10.1111/bpa.12177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Lammie GA. Pathology of small vessel stroke. Br Med Bull. 2000;56:296–306. doi: 10.1258/0007142001903229. [DOI] [PubMed] [Google Scholar]
- 87.Tarumi T, Ayaz Khan M, Liu J, Tseng BY, Parker R, Riley J, Tinajero C, Zhang R. Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility. J Cereb Blood Flow Metab. 2014;34:971–978. doi: 10.1038/jcbfm.2014.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.O’Rourke MF. Arterial aging: pathophysiological principles. Vasc Med. 2007;12:329–341. doi: 10.1177/1358863X07083392. [DOI] [PubMed] [Google Scholar]
- 89.Scuteri A, Nilsson PM, Tzourio C, Redon J, Laurent S. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens. 2011;29:1469–1477. doi: 10.1097/HJH.0b013e328347cc17. [DOI] [PubMed] [Google Scholar]
- 90.Harukuni I, Bhardwai A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin. 2006;24:1–21. doi: 10.1016/j.ncl.2005.10.004. [DOI] [PubMed] [Google Scholar]
- 91.Riddle DR, Sonntag WE, Lichtenwalner RJ. Microvascular plasticity in aging. Ageing Res Rev. 2003;2:149–168. doi: 10.1016/S1568-1637(02)00064-8. [DOI] [PubMed] [Google Scholar]
- 92.Hatano Y, Narumoto J, Shibata K, Matsuoka T, Tamiguchi S, Hata Y, Yamada K, Yaku H, Fukui K. White-matter hyperintensities predict delirium after cardiac surgery. Am J Geriatr Psychiatry. 2013;21:938–945. doi: 10.1016/j.jagp.2013.01.061. [DOI] [PubMed] [Google Scholar]
- 93.Otomo S, Maekawa K, GotoT BT, Yoshitake A. Pre-existing cerebral infarcts as a risk factor for delirium after coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2013;17:799–804. doi: 10.1093/icvts/ivt304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Root JC, Pryor KO, Downey R, Alici Y, Davis ML, Holodni A, Korc-Grodzicki B, Ahles T. Association of pre-operative brain pathology with post-operative delirium in a cohort of non-small cell lung cancer patients undergoing surgical resection. Psychooncology. 2013;22:2087–2094. doi: 10.1002/pon.3262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Cavallari M, Hshieh TT, Guttmann CR, Ngo LH, Meier DS, Schmitt EM, Marcantonio ER, Jones RN, Kosar CM, Fong TG, Press D, Inouye SK, Alsop DC, SAGES Study Group Brain atrophy and white-matter hyperintensities are not significantly associated with incidence and severity of postoperative delirium in older persons without dementia. Neurobiol Aging. 2015;36:2122–2129. doi: 10.1016/j.neurobiolaging.2015.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Hshieh TT, Dai W, Cavallari M, Guttmann CR, Meier DS, Schmitt EM, Dickerson BC, Press DZ, Marcantonio ER, Jones RN, Gou YR, Travison TG, Fong TG, Ngo L, Inouye SK, Alsop DC, SAGES Study Group Cerebral blood flow MRI in the nondemented elderly is not predictive of post-operative delirium but is correlated with cognitive performances. J Cereb Blood Flow Metab. 2017;37:1386–1397. doi: 10.1177/0271678X16656014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Schoen J, Meyerrose J, Paarmann H, Heringlake M, Hueppe M, Berger KU. Preoperative regional cerebral oxygen saturation is a predictor of postoperative delirium in on-pump cardiac surgery patients: a prospective observational trial. Crit Care. 2011;15:R218. doi: 10.1186/cc10454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7:a020412. doi: 10.1101/cshperspect.a020412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–185. doi: 10.1124/pr.57.2.4. [DOI] [PubMed] [Google Scholar]
- 100.Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41–53. doi: 10.1038/nrn1824. [DOI] [PubMed] [Google Scholar]
- 101.Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J. 2015;282:4067–4079. doi: 10.1111/febs.13412. [DOI] [PubMed] [Google Scholar]
- 102.Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19:182–189. doi: 10.1038/nn.4201. [DOI] [PubMed] [Google Scholar]
- 103.Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O’Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508:55–60. doi: 10.1038/nature13165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Erickson MA, Banks WA. Age-associated changes in the immune system and blood-brain barrier functions. Int J Mol Sci. 2019;20:1632. doi: 10.3390/ijms20071632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klünemann HH, Schuierer G, Schlachetzki F. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012;43:514–523. doi: 10.1161/STROKEAHA.111.627562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease – systematic review and meta-analysis. Neurobiol Aging. 2009;30:337–352. doi: 10.1016/j.neurobiolaging.2007.07.015. [DOI] [PubMed] [Google Scholar]
- 107.Senatorov VV Jr, Friedman AR, Milikowski DZ, Ofer J, Saar-Ashkenazy R, Charbash A, Jahan N, Chin G, Mihaly E, Lin JM, Ramsay HJ, Moghbel A, Preininger MK, Eddings CR, Harrison HV, Patel R, Shen Y, Ghanim H, Sheng H, Veksler R, Sudmant PH, Becker A, Hart B, Rogawski MA, Dillin A, Friedman A, Kaufer D (2019) Blood-brain barrier dysfunction in aging induces hyper-activation of TGF-beta signaling and chronic yet reversible neural dysfunction. BioRxiv. 10.1101/537431
- 108.Chen CP, Chen RL, Preston JE. The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma. Exp Gerontol. 2012;47:323–328. doi: 10.1016/j.exger.2012.01.008. [DOI] [PubMed] [Google Scholar]
- 109.Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296–302. doi: 10.1016/j.neuron.2014.12.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Nation DA, Sweeney MD, Montagne A, Sagare AP, D’Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:270–276. doi: 10.1038/s41591-018-0297-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Erdö F, Denes L, de Lange E. Age-associated physiological and pathological changes at the blood-brain barrier: a review. J Cereb Blood Flow Metab. 2017;37:4–24. doi: 10.1177/0271678X16679420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1–12. doi: 10.1016/j.bbi.2016.03.010. [DOI] [PubMed] [Google Scholar]
- 113.Acharya NK, Goldwaser EL, Forsberg MM, Godsey GA, Johnson CA, Sarkar A, DeMarshall C, Kosciuk MC, Dash JM, Hale CP, Leonard DM, Appelt DM, Nagele RG. Sevoflurane and Isoflurane induce structural changes in brain vascular endothelial cells and increase blood-brain barrier permeability: possible link to postoperative delirium and cognitive decline. Brain Res. 2015;1620:29–41. doi: 10.1016/j.brainres.2015.04.054. [DOI] [PubMed] [Google Scholar]
- 114.Johanson C, Silverberg G, Donahue J, Duncan J, Stopa E. Choroid plexus and CSF in Alzheimer’s disease: altered expression and transport of proteins and peptides. In: Zheng W, Chodobski A, editors. The blood-cerebrospinal fluid barrier. Boca Raton: CRC Press; 2004. pp. 307–339. [Google Scholar]
- 115.Johanson CE, Duncan JA, 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008;5:10. doi: 10.1186/1743-8454-5-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Rubenstein E. Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged. Lancet. 1998;351:383–385. doi: 10.1016/S0140-6736(97)09234-9. [DOI] [PubMed] [Google Scholar]
- 117.Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer’s disease, normalpressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2003;2:506–511. doi: 10.1016/S1474-4422(03)00487-3. [DOI] [PubMed] [Google Scholar]
- 118.Hassan I, Shing C, Bajraszewski CE, Gleason A, Hayhow BD, Velakoulis D. Osmotic demyelination syndrome: an under-recognised cause of delirium? Aust N Z J Psychiatry. 2013;47:287–288. doi: 10.1177/0004867412459813. [DOI] [PubMed] [Google Scholar]
- 119.Trillo-Contreras JL, Ramírez-Lorca R, Hiraldo-González L, Sánchez-Gomar I, Galán-Cobo A, Suárez-Luna N, Sánchez de Rojas-de Pedro E, Toledo-Aral JJ, Villadiego J, Echevarría M. Combined effects of aquaporin-4 and hypoxia produce age-related hydrocephalus. Biochem Biophys Acta Mol Basis Dis. 2018;1864:3515–3526. doi: 10.1016/j.bbadis.2018.08.006. [DOI] [PubMed] [Google Scholar]
- 120.Filippidis AS, Carozza RB, Rekate HL. Aquaporins in brain edema and neuropathological conditions. Int J Mol Sci. 2016;18:55. doi: 10.3390/ijms18010055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Nedergaard M. Neuroscience. Garbage truck of the brain Science. 2013;340:1529–1530. doi: 10.1126/science.1240514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J. The glymphatic system and waste clearance with brain aging: a review. Gerontology. 2019;65:106–119. doi: 10.1159/000490349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol. 2005;71:1–52. doi: 10.1016/S0070-2153(05)71001-2. [DOI] [PubMed] [Google Scholar]
- 124.Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489–1499. doi: 10.1172/JCI10498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9:907–913. doi: 10.1038/nm890. [DOI] [PubMed] [Google Scholar]
- 126.Crossgrove JS, Li GJ, Zheng W. The choroid plexus removes β-amyloid from brain cerebrospinal fluid. Exp Biol Med (Maywood) 2005;230:771–776. doi: 10.1177/153537020523001011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Donahue JE, Flaherty SL, Johanson CE, Duncan JA, 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG. RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease. Acta Neuropathol. 2006;112:405–415. doi: 10.1007/s00401-006-0115-3. [DOI] [PubMed] [Google Scholar]
- 128.Li L, Zhang X, Yang D, Luo G, Chen S, Le W. Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP. Neurobiol Aging. 2009;30:1091–1098. doi: 10.1016/j.neurobiolaging.2007.10.011. [DOI] [PubMed] [Google Scholar]
- 129.Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α. J Neurochem. 2009;108:1045–1056. doi: 10.1111/j.1471-4159.2008.05858.x. [DOI] [PubMed] [Google Scholar]
- 130.Bulbarelli A, Lonati E, Brambilla A, Orlando A, Cazzaniga E, Piazza F, Ferrarese C, Masserini M, Sancini G. Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol Cell Neurosci. 2012;49:415–422. doi: 10.1016/j.mcn.2012.01.007. [DOI] [PubMed] [Google Scholar]
- 131.Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, de Flores R, Mutlu J, de la Sayette V, Eustache F, Chételat G, Rauchs G. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging. 2016;41:107–114. doi: 10.1016/j.neurobiolaging.2016.02.009. [DOI] [PubMed] [Google Scholar]
- 132.You JC, Jones E, Cross DE, Lyon AC, Kang H, Newberg AB, Lippa CF. Association of β-amyloid burden with sleep dysfunction and cognitive impairment in elderly individuals with cognitive disorders. JAMA New Open. 2019;2:e1913383. doi: 10.1001/jamanetworkopen.2019.13383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Serot JM, Christmann D, Dubost T, Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1997;63:506–508. doi: 10.1136/jnnp.63.4.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Payne BA, Chinnery PF. Mitochondrial dysfunction in aging: much progress but many unsolved questions. Biochim Biophys Acta. 2015;1847:1347–1353. doi: 10.1016/j.bbabio.2015.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300. doi: 10.1093/geronj/11.3.298. [DOI] [PubMed] [Google Scholar]
- 136.Catic A. Cellular metabolism and aging. Prog Mol Biol Transl Sci. 2018;155:85–107. doi: 10.1016/bs.pmbts.2017.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Karlidag R, Unal S, Sezer OH, Bay Karabulut A, Battaloǧlu B, But A, Ozcan C. The role of oxidative stress in postoperative delirium. Gen Hosp Psychiatry. 2006;28:418–423. doi: 10.1016/j.genhosppsych.2006.06.002. [DOI] [PubMed] [Google Scholar]
- 138.Eertmans W, De Deyne C, Genbrugge C, Marcus B, Bouneb S, Beran M, Fret T, Gutermann H, Boer W, Vander Laenen M, Heylen R, Mesotten D, Vanelderen P, Jans F. Association between postoperative delirium and postoperative cerebral oxygen desaturation in older patients after cardiac surgery. Br J Anaesth. 2020;124:146–153. doi: 10.1016/j.bja.2019.09.042. [DOI] [PubMed] [Google Scholar]
- 139.Ross JM, Öberg J, Brené S, Coppotelli G, Terzioglu M, Pernold K, Goiny M, Sitnikov R, Kehr J, Trifunovic A, Larsson NG, Hoffer BJ, Olson L. High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci USA. 2010;107:20087–20092. doi: 10.1073/pnas.1008189107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Grimm A, Eckert A. Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem. 2017;143:418–431. doi: 10.1111/jnc.14037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Jiang T, Cadenas E. Astrocytic metabolic and inflammatory changes as a function of age. Aging Cell. 2014;13:1059–1067. doi: 10.1111/acel.12268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Franceschi C, Bonafé M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. doi: 10.1111/j.1749-6632.2000.tb06651.x. [DOI] [PubMed] [Google Scholar]
- 143.Fonken LK, Frank MG, Gaudet AD, Maier SF. Stress and aging act through common mechanisms to elicit neuroinflammatory priming. Brain Behav Immun. 2018;73:133–148. doi: 10.1016/j.bbi.2018.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Cornejo F, von Bernhardi R. Age-dependent changes in the activation and regulation of microglia. Adv Exp Med Biol. 2016;949:205–226. doi: 10.1007/978-3-319-40764-7_10. [DOI] [PubMed] [Google Scholar]
- 145.Udeochu JC, Shea JM, Villeda SA. Microglia communication: parallels between aging and Alzheimer’s disease. Clin Exp Neuroimmunol. 2016;7:114–125. doi: 10.1111/cen3.12307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Tay TL, Savage JC, Hui CW, Bisht K, Tremblay MÈ. Microglia across the lifespan: from origin to function in brain development, plasticity and cognition. J Physiol. 2017;595:1929–1945. doi: 10.1113/JP272134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol. 2017;79:619–643. doi: 10.1146/annurev-physiol-022516-034406. [DOI] [PubMed] [Google Scholar]
- 148.Streit WJ, Xue QS. The brain’s aging immune system. Aging Dis. 2010;1:254–261. [PMC free article] [PubMed] [Google Scholar]
- 149.Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT. Age-related alterations in the dynamic behavior of microglia. Aging Cell. 2011;10:263–276. doi: 10.1111/j.1474-9726.2010.00660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Niraula A, Sheridan JF, Godbout JP. Microglia priming with aging and stress. Neuropsychopharmacology. 2017;42:318–333. doi: 10.1038/npp.2016.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Bachstetter AD, Ighodaro ET, Hassoun Y, Aldeiri D, Neltner JH, Patel E, Abner EL, Nelson PT. Rod-shaped microglia morphology is associated with aging in 2 human autopsy series. Neurobiol Aging. 2017;52:98–105. doi: 10.1016/j.neurobiolaging.2016.12.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Bisht K, Sharma KP, Lecours C, Sánchez MG, El Hajj H, Milior G, Olmos-Alonso A, Gómez-Nicola D, Luheshi G, Vallières L, Branchi I, Maggi L, Limatola C, Butovsky O, Tremblay MÈ. Dark microglia: a new phenotype predominantly associated with pathological states. Glia. 2016;64:826–839. doi: 10.1002/glia.22966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Ravji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW. Immunosenescence of microglia and macrophages: impact of the ageing central nervous system. Brain. 2016;139:653–661. doi: 10.1093/brain/awv395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Uchikado H, Akiyama H, Kondo H, Ikeda K, Tsushiya K, Kato M, Oda T, Togo T, Iseki E, Kosaka K. Activation of vascular endothelial cells and perivascular cells by systemic inflammation – an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol. 2004;107:341–351. doi: 10.1007/s00401-003-0815-x. [DOI] [PubMed] [Google Scholar]
- 155.Perry VH, Holmes C. Microglial priming in neurodegenerative diseases. Nat Rev Neurol. 2014;10:217–224. doi: 10.1038/nrneurol.2014.38. [DOI] [PubMed] [Google Scholar]
- 156.Safaiyan S, Kannaiyan N, Snaidero N, Brioschi S, Biber K, Yona S, Edinger AL, Jung S, Rossner MJ, Simons M. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat Neurosci. 2016;19:995–998. doi: 10.1038/nn.4325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Piva S, McCreadie VA, Latronico N. Neuroinflammation in sepsis: sepsis associated delirium. Cardiovasc Hematol Disord Drug Targets. 2015;15:10–18. doi: 10.2174/1871529X15666150108112452. [DOI] [PubMed] [Google Scholar]
- 158.Johanson A, Olsson T, Carlberg B, Karlsson K, Fagerlund M. Hypercorticolism after stroke – partly cytokine-mediated? J Neurol Sci. 1997;147:43–47. doi: 10.1016/S0022-510X(96)05308-7. [DOI] [PubMed] [Google Scholar]
- 159.Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. The immunology of delirium. Neuroimmunomodulation. 2014;21:72–78. doi: 10.1159/000356526. [DOI] [PubMed] [Google Scholar]
- 160.Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56. doi: 10.1038/nrn2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet. 2010;375:773–775. doi: 10.1016/S0140-6736(09)61158-2. [DOI] [PubMed] [Google Scholar]
- 162.van Munster BC, Bisschop PH, Zwinderman AH, Korevaar JC, Endert E, Wiersinga WJ, van Oosten HE, Goslings JC, de Rooij SE. Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn. 2010;74:18–23. doi: 10.1016/j.bandc.2010.05.010. [DOI] [PubMed] [Google Scholar]
- 163.Westhoff D, Witlox J, Koenderman L, Kalisvaart KJ, de Jonghe JF, van Stijn MF, Houdijk AP, Hoogland IC, Maclullic AM, van Westerloo DJ, van de Beek D, Eikelenboom P, van Gool WA. Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients. J Neuroinflammation. 2013;10:122. doi: 10.1186/1742-2094-10-122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Vasunilashom SM, Ngo L, Inouye SK, Libermann TA, Jones RN, Alsop DC, Guess J, Jastrzebski S, McElhaney JE, Kuchel GA, Marcantonio ER. Cytokines and postoperative delirium in older patients undergoing major elective surgery. J Gerontol A Biol Sci Med Sci. 2015;70:1289–1295. doi: 10.1093/gerona/glv083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Hirsch J, Vacas S, Terrando N, Yuan M, Sands LP, Kramer J, Bozic K, Maze MM, Leung JM. Perioperative cerebrospinal fluid and plasma inflammatory markers after orthopedic surgery. J Neuroinflammation. 2016;13:211. doi: 10.1186/s12974-016-0681-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Kowalska K, Klimiec E, Weglarczyk K, Pera J, Slowik A, Siedlar M, Dziedzic T. Reduced ex vivo release of pro-inflammatory cytokines and elevated plasma interleukin-6 are inflammatory signatures of post-stroke delirium. J Neuroinflammation. 2018;15:111. doi: 10.1186/s12974-018-1156-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Conti E, Andreoni S, Tomaselli D, Storti B, Brovelli F, Acampora R, Da Re F, Apollonio I, Ferrarese C, Tremolizzo L. Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium. Neurol Sci. 2020;42:1003–1007. doi: 10.1007/s10072-020-04608-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.van Munster BC, Aronica E, Zwinderman AH, Eikelenboom P, Cunningham C, de Rooij SE. Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res. 2011;14:615–622. doi: 10.1089/rej.2011.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Beloosesky Y, Hendel D, Weiss A, Hershkovicz A, Grinblat J, Pirotsky A, Barak V. Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. J Gerontol A Biol Sci Med Sci. 2007;62:420–426. doi: 10.1093/gerona/62.4.420. [DOI] [PubMed] [Google Scholar]
- 170.de Rooij SE, van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res. 2007;62:521–525. doi: 10.1016/j.jpsychores.2006.11.013. [DOI] [PubMed] [Google Scholar]
- 171.Cape E, Hall RJ, van Munster BC, de Vries A, Howie SE, Pearson A, Middleton SD, Gillies F, Armstrong IR, White TO. Cunningham C, de Rooij SE, MacLullich AM. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture. J Psychosom Res. 2014;77:219–225. doi: 10.1016/j.jpsychores.2014.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO. Associations between delirium and preoperative cerebrospinal fluid C-reactive protein, interleukin-6, and interleukin-6 receptor in individuals with acute hip fracture. J Am Geriatr Soc. 2016;64:1456–1463. doi: 10.1111/jgs.14238. [DOI] [PubMed] [Google Scholar]
- 173.Slor CJ, Witlox J, Adamis D, Jansen RW, Houdijk AP, van Gool WA, de Jonghe JF, Eikelenboom P. The trajectory of C-reactive protein serum levels in older hip fracture patients with postoperative delirium. Int J Geriatr Psychiatr. 2019;34:1438–1446. doi: 10.1002/gps.5139. [DOI] [PubMed] [Google Scholar]
- 174.Sajjat MU, Blennow K, Knapskog AB, Idland AV, Chaudhry FA, Wyller TB, Zetterberg H, Watne LO. Cerebrospinal fluid levels of interleukin-8 in delirium, dementia, and cognitively healthy patients. J Alzheimers Dis. 2020;73:1363–1372. doi: 10.3233/JAD-190941. [DOI] [PubMed] [Google Scholar]
- 175.Simons KS, van den Boogaard M, Hendriksen E, Gerretsen J, van der Hoeven JG, Pickkers P, de Jager CPC. Temporal biomarker profiles and their association with ICU acquired delirium: a cohort study. Crit Care. 2018;22:137. doi: 10.1186/s13054-018-2054-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Jackson JC, Gordon SM, Hart RP, Hopkins RO, Ely EW. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev. 2004;14:87–98. doi: 10.1023/B:NERV.0000028080.39602.17. [DOI] [PubMed] [Google Scholar]
- 177.MacLullich AM, Beaglehole A, Hall RJ, Meagher DJ. Delirium and long-term cognitive impairment. Int Rev Psychiatry. 2009;21:30–42. doi: 10.1080/09540260802675031. [DOI] [PubMed] [Google Scholar]
- 178.Goldberg TE, Chen C, Wang Y, Jung E, Swanson A, Ing C, Garcia PS, Whittington RA, Moitra V. Association of delirium with long-term cognitive decline. A meta-analysis JAMA Neurol. 2020;77:1–9. doi: 10.1001/jamaneurol.2020.2273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Gross AL, Jones RN, Haltemariam DA, Fong TG, Tammet D, Quach L, Schmitt E, Yap L, Inouye SK. Delirium and long-term cognitive trajectory among persons with dementia. Arch Intern Med. 2012;172:1324–1331. doi: 10.1001/archinternmed.2012.3203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 180.Weiner MF. Impact of delirium on the course of Alzheimer disease. Arch Neurol. 2012;69:1639–1640. doi: 10.1001/archneurol.2012.2703. [DOI] [PubMed] [Google Scholar]
- 181.Davis DH, Muniz-Terrera G, Keage H, Rahkonen T, Oinas M, Matthews FE, Cunningham C, Polvikoski T, Sulkava R, MacLullich AM, Brayne C. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135:2809–2816. doi: 10.1093/brain/aws190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Davis DH, Muniz-Terrera G, Keage HA, Stephan BC, Fleming J, Ince PG, Matthews FE, Cunningham C, Ely EW, MacLullick AMJ, Brayne C, Epidemiological Clinicopathological Studies in Europe (EClipSE) Collaborative Members Association of delirium with cognitive decline in late life. A neuropathologic study of 3 population-based cohort studies. JAMA Psychiatry. 2017;74:244–251. doi: 10.1001/jamapsychiatry.2016.3423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA. Neuropathologic basis of age-associated brain atrophy. JAMA Neurol. 2013;70:616–622. doi: 10.1001/jamaneurol.2013.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Xekardaki A, Kövari E, Gold G, Papadimitropoulou A, Giacobini E, Herrmann F, Giannakopoulos P, Bouras C. Neuropathological changes in aging brain. Adv Exp Med Biol. 2015;821:11–17. doi: 10.1007/978-3-319-08939-3_6. [DOI] [PubMed] [Google Scholar]
- 185.Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76:3–19. doi: 10.3233/JAD-200581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Mirfazeli FS, Sarabi-Jamab A, Jahanbakhshi A, Kordi A, Javadnia P, Shariat SV, Aloosh O, Almasi-Dooghaee M, Faiz SH. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories. Sci Rep. 2020;10:20957. doi: 10.1038/s41598-020-78050-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Sharshar T, Carlier R, Bernard F, Guidoux C, Brouland JP, Nardi O, de la Grandmaison GL, Aboab J, Gray F, Menon D, Annane D. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 2007;33:798–806. doi: 10.1007/s00134-007-0598-y. [DOI] [PubMed] [Google Scholar]
- 188.Morandi A, Rogers BP, Gunther ML, Merkle K, Pandharipande P, Girard TD, Jackson JC, Thompson J, Shintani AK, Geevarghese S, Miller RR, 3rd, Canonico A, Cannistraci CJ, Gore JC, Ely EW, Hopkins RO, VISIONS investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study. Crit Care Med. 2012;40:2182–2189. doi: 10.1097/CCM.0b013e318250acdc. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Cavallari M, Dai W, Guttmann CR, Meier DS, Ngo LH, Hshieh TT, Fong TG, Schmitt E, Press DZ, Travison TG, Marcantonio ER, Jones RN, Inouye SK, Alsop DC, SAGES Study Group Longitudinal diffusion changes following postoperative delirium in older people without dementia. Neurology. 2017;89:1020–1027. doi: 10.1212/WNL.0000000000004329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Gunther ML, Morandi A, Krauskopf E, Pandharipande P, Girard TD, Jackson JC, Thompson J, Shintani AK, Geevarghese S, Miller RR, 3rd, Canonico A, Merkle K, Cannistraci CJ, Rogers BP, Gatenby JC, Heckers S, Gore JC, Hopkins RO, Ely EW, VISIONS investigartion, VISualizing Icu SurvivOrs Neuroradiological Sequelae The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study. Clin Care Med. 2012;40:2022–2032. doi: 10.1097/CCM.0b013e318250acc0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.van Munster BC, Korevaar JC, Korse CM, Bonfrer JM, Zwinderman AH, de Rooij SE. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry. 2010;25:234–239. doi: 10.1002/gps.2326. [DOI] [PubMed] [Google Scholar]
- 192.Hatherill S, Fisher AJ. Delirium in children and adolescents: a systematic review of the literature. J Psychosom Res. 2010;68:337–344. doi: 10.1016/j.jpsychores.2009.10.011. [DOI] [PubMed] [Google Scholar]
- 193.Harris J, Ramelet AS, van Dijk M, Pokorna P, Wielenga J, Tume L, Tibboel D, Ista E. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med. 2016;42:972–986. doi: 10.1007/s00134-016-4344-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Malas N, Brahmbhatt K, McDermott C, Smith A, Ortiz-Aguayo R, Turkel S. Pediatric delirium: evaluation, management, and special considerations. Curr Psychiatry Rep. 2017;19:65. doi: 10.1007/s11920-017-0817-3. [DOI] [PubMed] [Google Scholar]
- 195.Patel AK, Bell MJ, Traube C. Delirium in pediatric critical care. Pediatr Clin N Am. 2017;64:1117–1132. doi: 10.1016/j.pcl.2017.06.009. [DOI] [PubMed] [Google Scholar]
- 196.Smith HA, Gangopadhyay M, Goben CM, Jakobowski NL, Chestnut MH, Savage S, Rutherford MT, Denton D, Thomson JL, Chandrasekhar R, Acton M, Newman J, Noori HP, Terrell MK, Williams SR, Griffith K, Cooper TJ, Ely EW, Fuchs DC, Pandharipande PP. The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically ill infants and children. Crit Care Med. 2016;44:592–600. doi: 10.1097/CCM.0000000000001428. [DOI] [PMC free article] [PubMed] [Google Scholar]